NEB® scientists, collaborators and customers to showcase data on new and upcoming NEBNext® technologies, including an enzymatic alternative to bisulfite sequencing for methylome analysis, expanded target enrichment and RNA depletion offerings, and a convenient new option for NEBNext reagents used in Oxford Nanopore Technologies® library preparation.
| IPSWICH, Mass., Feb. 27, 2019 /PRNewswire/ -- At this year’s Advances in Genome Biology and Technology (AGBT) General Meeting, New England BioLabs, Inc. scientists and collaborators will present a broad range of sample preparation technologies, as well as basic research findings, that address issues in various next generation sequencing areas.
One highlight will be NEB’s new NEBNext Enzymatic Methyl-seq Kit (EM-seq™), an alternative to bisulfite sequencing for methylome analysis. Several presentations and posters will describe this novel enzyme-based technology that offers unmatched performance, including superior sensitivity of detection of 5-mC and 5-hmC and uniformity of GC coverage. This year’s meeting will be held from February 27th – March 2nd in Marco Island, Florida. During the conference, NEB will be based in the Osprey 3 Suite. Below is a preview of activities during the conference: Presentations:
A number of posters will be presented during the conference (see list below) and also displayed in Osprey 3. There will be several opportunities to meet with our Research and Development Scientists and learn more about topics including the following: An enzymatic alternative to bisulfite sequencing with superior performance: The upcoming NEBNext Enzymatic Methyl-seq (EM-seq™) products provide an enzymatic alternative to bisulfite sequencing, combined with high-efficiency, streamlined library preparation. This new technology conveys multiple advantages, and enables detection of more CpGs with fewer sequence reads. NEBNext Companion Module for Oxford Nanopore Technologies Ligation Sequencing: Available soon, this will include the NEBNext DNA repair, End prep and Ligation reagents recommended for use alongside Oxford Nanopore Technologies SQK-LSK109 on their sequencing platforms, at volumes tailored for this workflow, simplifying the ordering process and reducing waste. RNA depletion: NEB will preview new options for depletion of abundant RNAs, including globin and bacterial samples, as well as a custom solution. NEBNext Direct® Custom Ready Panels: Easy and rapid customization of NEBNext Direct target enrichment technology is now possible. Custom panels can be designed from a list of 850 genes, sequence-verified and received within two weeks. Conference posters:
An evening with NEBNext scientists A full summary of NEB’s activities at the 2019 AGBT conference, can be found here For more information on the NEBNext portfolio of reagents for sample preparation, visit www.NEBNext.com About New England Biolabs NEB®, NEW ENGLAND BIOLABS®, NEBNEXT® and NEBNEXT DIRECT® are registered trademarks of New England Biolabs, Inc. ULTRA™ is a trademark of New England Biolabs, Inc. OXFORD NANOPORE TECHNOLOGIES® is a registered trademark of Oxford Nanopore Technologies, Inc.
SOURCE New England Biolabs |
View original content to download multimedia:
